Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Seroprevalence of SARS-CoV-2: Insights into the epidemiology of the pandemic

Journal of Infection and Public Health(2023)10.1016/j.jiph.2023.05.036Source: DataRank Database

Seroprevalence of SARS-CoV-2: Insights into the epidemiology of the pandemic is a research paper published in Journal of Infection and Public Health (2023). On theSindex it has a DataRank of 0.208. It has been cited 3 times.

N/A

0.208DataRank · unranked

Scored on demand from live citation data

Open Access3 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (1 grants)Impact (FWCI 0.51)OA: goldTopics (44)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.208

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (13)

Muhammad Waqar ORCID,Ayesha Akram ORCID,Shazia Rafique ORCID,Gauhar Rehman ORCID,Muhammad Idrees ORCID

Live enrichment

PubMed:37300952 OpenAlex:https://openalex.org/W4379057614

Deanship of Scientific Research, King Khalid University

Grant: 2/100/44

FWCI

0.51

Citation Percentile

0.6%

Citation Trend

2023

2024

2025

goldLicense: cc-by-nc-nd

journalhttps://doi.org/10.1016/j.jiph.2023.05.036

publisherhttps://doi.org/10.1016/j.jiph.2023.05.036

publisherhttps://api.elsevier.com/content/article/PII:S1876034123002022?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1876034123002022?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37300952

Fields of Study

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesImmune responses and vaccinationsFemaleMaleHumansSARS-CoV-2PandemicsSeroepidemiologic StudiesCOVID-19Antibodies, ViralImmunoglobulin G

MeSH Terms

COVID-19SARS-CoV-2Antibodies, ViralFemaleHumansImmunoglobulin GMaleSeroepidemiologic StudiesPandemics

Keywords

PandemicSeroprevalenceSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakVirologyEpidemiologyMedicineBetacoronavirusCoronavirus InfectionsOutbreakImmunologyInfectious disease (medical specialty)AntibodyInternal medicineSerologyDiseaseAntibodiesIgGMalakandPakistanSARS-CoV-2Seroepidemiology

Sustainable Development Goals

SDG 0: Good health and well-being